Taizo Uchimoto

27PUBLICATIONS
28CO-AUTHORS
Predictive and prognostic markersRadiation therapyPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|May 17, 2026
Development of a prognostic model for elderly patients with metastatic clear cell renal cell carcinoma treated with first-line immuno-oncology combination therapy.

|Apr 20, 2026
Author's reply to 'Bayesian interpretation of febrile neutropenia risk and primary G-CSF prophylaxis during darolutamide triplet therapy'.

|Mar 12, 2026
Real-world comparison of enzalutamide and apalutamide in metastatic hormone-sensitive prostate cancer: a multi-institutional propensity score-matched analysis.

Kazuki Nishimura, Kensuke Hirosuna, Heima Niigawa

|Feb 03, 2026
Age-stratified clinical outcomes and adverse events in patients with metastatic castration-sensitive prostate cancer receiving triplet therapy with darolutamide, androgen deprivation therapy, and docetaxel.

Taizo Uchimoto, Kensuke Hirosuna, Heima Niigawa

|Jan 31, 2025
Association of body mass index and tumor response in metastatic urothelial carcinoma treated with enfortumab vedotin: data from the ULTRA-Japan consortium.

Taizo Uchimoto, Kengo Iwatsuki, Kazumasa Komura

|Oct 29, 2024
Predicting time to castration resistance with androgen-receptor signaling inhibitors in hormone-sensitive prostate cancer: data from ULTRA-Japan Consortium.

Taizo Uchimoto, Kengo Iwatsuki, Kazumasa Komura

Pageof 5

Frequent Collaborators

8 joint publications

Kohei Taniguchi

7 joint publications

Takuya Tsujino

6 joint publications

Kiyoshi Takahara

5 joint publications

Takahiro Kimura